Author:
Neklesa Taavi K.,Winkler James D.,Crews Craig M.
Subject
Pharmacology (medical),Pharmacology
Reference50 articles.
1. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies;Advani;Journal of Clinical Oncology,2012
2. Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes;Askari;Current Genomics,2010
3. Characterization of the FKBP-rapamycin-FRB ternary complex;Banaszynski;Journal of the American Chemical Society,2005
4. RNA interference (RNAi)-based therapeutics: Delivering on the promise?;Bobbin;Annual Review of Pharmacology and Toxicology,2016
5. Catalytic in vivo protein knockdown by small-molecule PROTACs;Bondeson;Nature Chemical Biology,2015
Cited by
404 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献